RecruitingNot ApplicableNCT07067996

Erector Spinae Plane Block for Analgesia During ESWL


Sponsor

Sohag University

Enrollment

60 participants

Start Date

Jun 13, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

this study aims to compare between efficacy of erector spinae plane block and conventional multimodal analgesia in Extracorporeal shock wave lithotripsy


Eligibility

Min Age: 21 YearsMax Age: 60 Years

Inclusion Criteria6

  • Adult Patients undergoing ESWL with 2-3 cm renal stones
  • patients between the ages of 21 and 60,
  • both sexes,
  • BMI ≥18≤30 kg/m²
  • Able to give informed consent.
  • Patients older than 18 years with American Society of Anesthesiologists Physical Status I or II and

Exclusion Criteria6

  • Coagulopathy or on anticoagulants
  • Infection at the ESPB injection site
  • BMI ≥30 kg/m²
  • Patient refusal.
  • patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women.
  • patients with a history of allergies to any study drugs

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREerector spinae plane block

erector spinae plane block will be given as intraoperive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

DRUGNalbuphine

Nalbuphine will be given as intraopertive analgesia for patients undergoing Extracorporeal shock wave lithotripsy


Locations(1)

Sohag University Hospital

Sohag, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07067996


Related Trials